Dr. Reddy’s Laboratories announces the launch of Melphalan Hydrochloride for Injection in the U.S. market. Dr. Reddy’s Laboratories Ltd. has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran* (melphalan hydrochloride) for Injection in the United States market as approved by the U.S. Food and Drug Administration. Alkeran for Injection is indicated for the palliative…
